No definition available.
Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
C3_THYROID_FOLLICULAR_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
364 |
4. Check minimum number of eventsNone |
364 |
5. Include endpointsNone |
364 |
6. Filter based on genotype QC (FinnGen only) |
364 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 364 | 240 | 124 |
| Unadjusted period prevalence (%) | 0.07 | 0.08 | 0.05 |
| Median age at first event (years) | 52.67 | 49.37 | 59.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 204
- Matched controls
- 2040
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
+∞
268.8
194
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
230.2
175
*
104
Kela drug reimbursment
Thyroid insufficiency
74.2
131.5
156
85
H03AA01
ATC
levothyroxine sodium; systemic
89.4
118.5
193
334
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
125.7
102.6
105
17
EP1AE
NOMESCO Finland
Neck ultrasound examination
57.7
83.7
98
32
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
1096.9
78.9
72
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
75.9
68
*
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
124.9
75.6
78
10
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
68.7
62
*
BAA60
NOMESCO Finland
Total thyroidectomy
47.6
46.5
56
16
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
56.0
43.8
51
12
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
37.7
35
*
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
34.3
32
*
ZX114
NOMESCO Finland
Intramuscular
47.8
32.6
39
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.8
29.9
119
396
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
40.4
27.5
34
10
130
Kela drug reimbursment
Malignant tumour
+∞
24.5
23
*
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
14.0
24.1
42
37
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
23.4
22
*
4CJ01
NOMESCO Finland
NA
+∞
23.4
22
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
21.2
20
*
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
+∞
20.1
19
*
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
+∞
19.1
18
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
22.4
16.9
24
12
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
25.7
16.8
23
10
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.8
14
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.5
14.1
86
355
WW200
NOMESCO Finland
Immunization
23.1
13.6
19
9
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
26.3
12.7
17
7
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
12.6
12
*
1930B
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA FOLLICULARE THYREOIDEAE]
+∞
12.6
12
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
19.6
12.3
18
10
WX402
NOMESCO Finland
General anaesthesia
4.5
11.7
44
118
Z51.88
ICD-10 Finland
Other specified medical care
12.9
11.6
20
17
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.6
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
11.6
11
*
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
+∞
11.6
11
*
H02AB02
ATC
dexamethasone; systemic
26.8
11.3
15
6
XX3DW
NOMESCO Finland
Time consuming IT work
8.4
11.0
24
32
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.5
10
*
8335/3-C73.9
ICD-O-3
Follicular carcinoma, minimally invasive of thyroid gland
+∞
10.5
10
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
10.5
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
10.5
10
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
93.8
8.5
9
*
WF002
NOMESCO Finland
Radical radiotherapy
93.8
8.5
9
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
93.8
8.5
9
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
JN5SN
NOMESCO Finland
NA
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
106
Kela drug reimbursment
Hypoparathyroidism
46.8
7.8
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
7.6
49
197
2506
FHL
Thyroidectomy
83.0
7.5
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
T71
ICPC
Malignant neoplasm thyroid
+∞
7.3
7
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
+∞
7.3
7
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
7.3
7
*
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
12.7
7.2
12
10
NK6AN
NOMESCO Finland
Total body bone isotope imaging
23.4
6.7
9
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
72.0
6.5
7
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
6.3
57
278
JN4AD
NOMESCO Finland
Body CT examination
6.7
6.3
15
24
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
+∞
6.3
6
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
116
Kela drug reimbursment
Prostate cancer
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
236
165
38.83
290.15
8.8
3.4
4.6
4.5
pmol/l
0.65
231
143
88
32
35.95
133.90
1.5
1.2
—
—
—
0
0
281
1321
5.94
51.01
11.8
5.4
1.2
1.2
mmol/l
2.36
224
1139
264
1202
5.35
49.22
9.5
4.9
1.2
1.2
mmol/l
1.51
253
1075
202
882
3.90
36.44
4.3
1.9
2.3
2.4
mmol/l
5.49
191
733
83
195
5.22
34.46
6.4
2.5
1.2
1.2
mmol/l
2.48
78
166
86
225
4.70
31.17
2.1
3.8
44.3
77.1
ng/l
9.21
74
199
337
2349
6.86
26.46
12.1
3.9
17.8
14.8
pmol/l
47.93
324
2146
53
139
4.29
18.71
3.4
1.6
4.3
4.7
ug/l
0.05
42
107
207
1219
2.62
17.96
4.1
3.5
—
—
—
0
0
200
1240
2.36
14.41
2.7
2.3
81.8
77.3
nmol/l
1.72
186
1092
289
2139
2.70
13.62
9.9
5.2
77.7
74.4
u/l
0.95
276
1969
188
1160
2.28
13.38
4.3
3.5
36.4
36.1
g/l
0.41
177
1073
208
1362
2.23
12.52
6.9
3.7
11.0
11.0
umol/l
0.06
197
1280
340
2797
4.27
12.38
16.6
4.7
3.0
1.9
mu/l
0.58
327
2569
225
1574
2.12
10.79
8.6
6.3
3.9
4.2
e9/l
1.38
191
1369
226
1660
1.95
8.58
4.4
4.0
6.5
6.7
mmol/l
0.69
212
1531
58
257
2.50
8.42
3.2
2.9
—
—
—
0
0
102
604
1.96
7.14
2.2
1.8
—
—
—
0
0
24
74
3.40
6.68
1.8
2.0
5.1
7.4
iu/l
—
10
24
64
328
2.15
6.59
2.7
4.8
1.1
1.0
mmol/l
1.73
57
292
24
79
3.18
6.04
2.3
2.0
—
—
—
0
0
141
988
1.70
5.43
2.6
2.9
—
—
—
0
0
112
768
1.66
4.54
4.8
3.7
0.0
0.0
estimate
0.00
48
253
7
6
11.86
4.29
4.0
1.0
17.3
13.5
u/ml
—
7
6
8
10
8.15
4.08
2.0
1.4
11.5
18.9
ug/l
—
8
10
150
1141
1.54
3.80
4.7
3.5
—
—
—
0
0
17
61
2.87
3.74
1.6
1.3
76.1
57.7
pmol/l
0.46
17
61
18
67
2.77
3.71
4.4
3.5
—
—
—
0
0
21
86
2.53
3.62
1.7
2.3
10830.2
3338.1
u/l
—
5
32
106
755
1.57
3.57
2.5
2.8
0.4
0.4
e6/l
0.01
80
564
311
2809
1.74
3.43
17.8
10.1
82.4
81.0
ml/min/173m2
0.56
269
2230
326
2986
1.88
3.41
19.1
11.3
20.1
21.4
mg/l
0.30
264
2279
333
3072
1.99
3.39
18.0
13.4
139.9
139.7
mmol/l
0.56
326
2973
11
32
3.51
3.36
1.0
1.4
—
—
—
0
0
333
3080
1.95
3.24
18.6
13.5
3.9
4.0
mmol/l
3.00
323
2981
5
5
10.11
2.98
1.2
1.0
—
—
—
0
0
280
2492
1.54
2.98
21.5
13.7
13.7
13.5
%
0.57
273
2446
180
1474
1.44
2.94
4.4
3.5
0.0
0.0
estimate
0.50
50
248
177
1449
1.43
2.88
4.3
3.5
0.0
0.0
estimate
0.00
51
254
37
217
1.78
2.60
1.3
1.3
63.3
132.0
iu/ml
1.28
16
94
174
1454
1.38
2.36
5.7
4.8
0.0
0.0
estimate
0.00
49
251
141
1145
1.38
2.26
3.7
3.5
24.9
70.5
ng/l
0.82
95
781
12
48
2.55
2.21
1.9
2.7
3.8
4.2
e9/l
0.27
12
48
12
49
2.50
2.12
1.9
3.1
59.8
57.1
%
0.34
12
49
90
694
1.39
1.94
2.6
2.2
3.9
3.0
mg/l
1.25
78
581
26
151
1.78
1.93
5.0
4.2
2.4
1.9
mmol/l
0.39
21
109
112
898
1.36
1.90
2.5
2.2
106.2
55.6
u/l
0.97
95
826
12
52
2.35
1.89
1.2
1.3
—
—
—
0
0
12
52
2.35
1.89
1.3
1.3
—
—
—
0
0
49
338
1.52
1.88
2.6
2.3
22.1
22.7
%
0.08
38
295
6
17
3.57
1.84
2.0
1.5
—
—
—
0
0
23
378
0.58
1.75
4.5
4.5
29.7
32.1
%
0.50
15
236
8
30
2.70
1.73
1.5
1.1
—
—
—
0
0
11
48
2.33
1.72
1.4
1.2
—
—
—
0
0
5
13
3.88
1.72
1.2
1.3
—
—
—
0
0
12
56
2.18
1.63
1.4
1.3
—
—
—
0
0
6
20
3.03
1.58
1.5
1.4
—
—
—
0
0
334
3191
1.57
1.57
12.4
8.4
24.1
25.1
u/l
0.73
325
3064
15
269
0.54
1.57
1.3
1.8
—
—
—
0
0
0
43
0.00
1.53
0.0
1.1
—
—
—
0
0
44
311
1.47
1.52
2.0
2.5
7.2
6.3
umol/l
0.13
37
268
0
44
0.00
1.52
0.0
1.3
—
4.2
—
0
21
7
27
2.62
1.52
1.3
1.0
—
—
—
0
0
6
22
2.76
1.44
1.2
1.2
—
—
—
0
0
243
2221
1.28
1.44
4.5
4.1
12.2
11.5
mm/h
0.24
224
2037
50
367
1.42
1.43
8.2
6.5
—
—
—
0
0
9
41
2.22
1.38
1.3
1.3
—
—
—
0
0
151
1309
1.26
1.37
3.2
2.7
101.2
96.1
ug/l
0.16
140
1205
5
17
2.97
1.36
1.6
1.1
—
—
—
0
0
5
17
2.97
1.36
1.6
1.1
—
—
—
0
0
5
17
2.97
1.36
1.6
1.1
—
—
—
0
0
9
42
2.17
1.34
1.4
1.2
—
—
—
0
0
9
43
2.12
1.31
1.1
1.3
—
—
—
0
0
89
728
1.29
1.28
3.3
2.3
358.1
10054.3
umol/l
4.21
76
635
6
26
2.33
1.19
3.2
2.6
13.3
13.2
%
—
6
26
84
690
1.28
1.17
1.5
1.5
20.7
21.3
nmol/l
0.16
78
592
34
249
1.40
1.02
1.5
3.3
2.5
1.9
mmol/l
0.48
24
199
6
28
2.16
0.92
1.5
1.1
—
—
—
0
0
6
29
2.09
0.89
1.3
1.1
—
—
—
0
0
8
43
1.88
0.88
1.3
1.5
—
—
—
0
0
6
30
2.02
0.87
1.2
3.2
—
34.3
—
0
9
36
276
1.34
0.84
5.2
6.2
1.2
1.5
mmol/l
0.28
27
218
45
357
1.30
0.84
19.4
20.1
1.0
1.3
inr
—
5
52
0
26
0.00
0.78
0.0
1.3
—
68.0
—
0
5
21
149
1.43
0.77
2.0
2.7
0.1
0.2
e6/l
0.60
21
143
50
408
1.26
0.76
2.0
1.7
—
—
—
0
0
287
2980
0.83
0.75
4.3
4.4
1.4
1.5
mmol/l
1.31
263
2757
207
1930
1.17
0.75
3.5
2.9
44.9
42.1
u/l
0.23
187
1807
7
39
1.81
0.73
1.3
1.2
—
—
—
0
0
48
393
1.26
0.71
2.8
1.8
30.0
29.4
s
0.21
48
381
9
145
0.61
0.71
3.2
1.6
—
—
—
0
0
9
58
1.57
0.70
1.6
1.1
—
—
—
0
0
73
627
1.21
0.70
1.8
1.7
520.1
7752379.4
pmol/l
0.50
62
516
55
460
1.23
0.68
2.0
2.5
1.4
1.1
e6/l
0.19
33
252
97
859
1.18
0.67
2.8
3.1
998.3
1336.8
ng/l
0.81
82
723
36
289
1.27
0.64
1.4
1.7
—
—
—
0
0
8
49
1.65
0.62
1.4
1.3
11.8
13.8
u/l
—
8
44
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
277
2868
0.86
0.58
3.8
3.9
1.3
1.3
mmol/l
0.93
255
2631
291
3000
0.85
0.57
4.3
4.4
4.7
4.7
mmol/l
0.21
270
2786
50
424
1.21
0.56
2.0
2.8
6.8
2.8
e6/l
0.40
28
219
10
66
1.53
0.53
1.5
1.2
—
—
—
0
0
9
134
0.66
0.52
1.3
1.5
—
—
—
0
0
6
40
1.51
0.52
1.2
1.0
—
—
—
0
0
46
393
1.20
0.49
3.8
2.6
0.8
0.8
ug/l
0.05
30
253
35
291
1.22
0.48
1.4
1.7
—
—
—
0
0
78
700
1.15
0.46
5.3
3.8
2.5
2.0
ug/l
0.58
68
632
30
361
0.82
0.46
2.2
2.1
—
—
—
0
0
7
50
1.41
0.45
1.0
1.3
—
—
—
0
0
22
175
1.27
0.44
1.8
1.5
—
—
—
0
0
14
105
1.35
0.41
7.2
4.8
25.5
25.0
mmol/l
0.32
14
99
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
2.4
—
775.1
—
0
16
282
2741
1.13
0.41
19.3
12.5
40.3
40.2
%
0.08
189
1989
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
299
3058
0.88
0.40
4.9
4.9
2.8
2.8
mmol/l
0.36
275
2831
22
178
1.25
0.40
1.3
1.4
—
—
—
0
0
27
224
1.22
0.39
2.7
2.0
59.7
69.2
ml/min/173m2
0.66
13
97
15
115
1.32
0.39
2.7
2.2
31.4
40.9
u/l
—
10
101
0
19
0.00
0.39
0.0
2.5
—
53.0
—
0
14
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
74
671
1.13
0.38
5.6
3.7
1.0
1.0
kg/l
0.08
17
88
181
1896
0.91
0.38
3.6
3.1
—
—
—
0
0
14
107
1.32
0.37
1.7
2.2
—
—
—
0
0
10
72
1.40
0.37
1.6
1.3
—
—
—
0
0
27
320
0.83
0.37
2.0
1.9
—
—
—
0
0
6
45
1.34
0.34
1.2
1.5
—
—
—
0
0
6
90
0.66
0.33
1.2
1.2
588.7
427.7
mg/l
—
6
82
6
47
1.28
0.32
2.5
1.3
0.5
0.5
nmol/l
—
6
42
7
100
0.69
0.31
1.1
1.4
—
—
—
0
0
273
2793
0.91
0.30
5.5
5.7
39.2
39.7
mmol/mol
0.45
250
2605
7
54
1.30
0.30
1.0
1.8
—
—
—
0
0
7
55
1.28
0.30
1.9
1.3
—
—
—
0
0
30
262
1.16
0.27
1.8
2.5
4.6
6.1
ug/l
0.36
25
229
61
563
1.10
0.25
4.7
3.7
19.5
24.0
%
1.87
30
257
18
152
1.19
0.24
1.1
1.0
—
—
—
0
0
5
41
1.22
0.22
1.2
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
17.8
—
0
10
0
12
0.00
0.21
0.0
1.2
—
348.0
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
59
630
0.92
0.19
1.4
1.7
0.9
1.1
mg/l
0.47
49
479
7
63
1.11
0.17
1.3
1.3
—
—
—
0
0
6
80
0.75
0.15
1.2
1.2
4.1
3.8
mmol/l
—
6
73
16
140
1.15
0.15
1.3
2.4
1.0
1.2
%
0.76
16
140
30
325
0.92
0.14
2.2
1.8
1.4
1.4
%
0.18
25
292
53
558
0.94
0.12
2.3
1.7
1540.5
1247.8
nmol/l
0.92
38
422
15
168
0.89
0.12
1.5
1.4
—
—
—
0
0
54
518
1.05
0.09
1.3
1.4
—
—
—
0
0
79
814
0.96
0.08
1.9
1.6
1.4
1.4
mmol/l
0.13
65
693
7
65
1.08
0.08
1.1
1.3
—
—
—
0
0
20
186
1.08
0.07
1.7
1.9
—
—
—
0
0
12
108
1.11
0.07
1.8
1.7
—
—
—
0
0
7
84
0.83
0.07
6.3
1.2
0.4
0.4
g/l
—
7
77
8
90
0.89
0.07
4.3
1.5
—
—
—
0
0
8
94
0.85
0.07
5.0
1.5
—
—
—
0
0
9
102
0.88
0.06
6.2
1.3
—
—
—
0
0
16
148
1.08
0.06
1.5
1.7
—
—
—
0
0
20
213
0.94
0.06
1.3
1.3
—
46.1
—
0
14
56
545
1.03
0.05
1.4
1.3
20.8
12.1
u/ml
0.29
24
212
123
1213
1.02
0.04
1.9
2.0
96.5
96.6
pmol/l
0.01
63
616
56
548
1.03
0.03
1.3
1.6
—
—
—
0
0
294
2952
0.98
0.03
4.5
4.4
5.8
5.9
mmol/l
0.79
271
2701
11
102
1.08
0.03
2.3
1.7
—
—
—
0
0
56
569
0.98
0.02
1.4
1.3
16.5
34.8
iu/ml
2.72
22
176
68
686
0.99
0.00
1.3
1.3
1.5
1.7
u/ml
0.13
22
195
11
114
0.96
0.00
1.5
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
7
79
0.88
0.00
6.3
1.2
40.6
38.4
g/l
—
7
69
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
10.8
—
0
9
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
9
96
0.94
0.00
1.6
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
42.2
—
0
6
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.8
—
140.2
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
56
560
1.00
0.00
3.4
3.7
283.0
351.4
ng/l
0.09
47
433
9
97
0.93
0.00
1.6
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
107.8
—
0
6
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
7
70
1.00
0.00
1.1
1.3
—
—
—
0
0
5
51
0.98
0.00
1.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_THYROID_FOLLICULAR_EXALLC – Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).